Virpax Pharmaceuticals Stock Market Value
| VRPX Stock | USD 0.47 0.10 17.54% |
| Symbol | Virpax |
Virpax Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Virpax Pharmaceuticals. If investors know Virpax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Virpax Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.25) | Return On Assets (0.91) | Return On Equity (3.62) |
The market value of Virpax Pharmaceuticals is measured differently than its book value, which is the value of Virpax that is recorded on the company's balance sheet. Investors also form their own opinion of Virpax Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Virpax Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virpax Pharmaceuticals' market value can be influenced by many factors that don't directly affect Virpax Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virpax Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Virpax Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virpax Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Virpax Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Virpax Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Virpax Pharmaceuticals.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Virpax Pharmaceuticals on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Virpax Pharmaceuticals or generate 0.0% return on investment in Virpax Pharmaceuticals over 30 days. Virpax Pharmaceuticals is related to or competes with Revelation Biosciences, Palisade Bio, Virax Biolabs, Quoin Pharmaceuticals, RenovoRx, Pasithea Therapeutics, and Nutriband. Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and dru... More
Virpax Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Virpax Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Virpax Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 44.98 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 10.96 |
Virpax Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Virpax Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Virpax Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Virpax Pharmaceuticals historical prices to predict the future Virpax Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (1.37) | |||
| Treynor Ratio | (0.14) |
Virpax Pharmaceuticals Backtested Returns
Virpax Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0297, which indicates the firm had a -0.0297% return per unit of risk over the last 3 months. Virpax Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Virpax Pharmaceuticals' Risk Adjusted Performance of (0.02), variance of 50.87, and Coefficient Of Variation of (3,058) to confirm the risk estimate we provide. The entity has a beta of 1.76, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Virpax Pharmaceuticals will likely underperform. At this point, Virpax Pharmaceuticals has a negative expected return of -0.21%. Please make sure to validate Virpax Pharmaceuticals' kurtosis, as well as the relationship between the rate of daily change and price action indicator , to decide if Virpax Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.22 |
Weak predictability
Virpax Pharmaceuticals has weak predictability. Overlapping area represents the amount of predictability between Virpax Pharmaceuticals time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Virpax Pharmaceuticals price movement. The serial correlation of 0.22 indicates that over 22.0% of current Virpax Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | 0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Virpax Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Virpax Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Virpax Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Virpax Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Virpax Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Virpax Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Virpax Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Virpax Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Virpax Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Virpax Pharmaceuticals Lagged Returns
When evaluating Virpax Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Virpax Pharmaceuticals stock have on its future price. Virpax Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Virpax Pharmaceuticals autocorrelation shows the relationship between Virpax Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Virpax Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Virpax Stock Analysis
When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.